Post-earnings recap
Reported
Tue, Oct 30, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report showed a positive surprise on EPS, which contributed to a slight increase in the stock price. The management's focus on R&D and strong performance in key areas indicates a commitment to future growth. However, the lack of revenue data and guidance leaves some uncertainty for investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.69 | N/A | +4.19% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of innovation and market presence.
Management highlighted strong performance in key therapeutic areas.
They noted ongoing investments in R&D to drive future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—